BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18398822)

  • 1. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays.
    Yi Y; Nowak NJ; Pacchia AL; Morrison C
    Genes Chromosomes Cancer; 2008 Aug; 47(8):639-48. PubMed ID: 18398822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
    Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
    Am J Pathol; 2001 Apr; 158(4):1355-62. PubMed ID: 11290553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].
    Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL
    Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
    Välimäki S; Forsberg L; Farnebo LO; Larsson C
    Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
    Pourani J; Kaserer K; Pfragner R
    Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
    Rücker FG; Bullinger L; Schwaenen C; Lipka DB; Wessendorf S; Fröhling S; Bentz M; Miller S; Scholl C; Schlenk RF; Radlwimmer B; Kestler HA; Pollack JR; Lichter P; Döhner K; Döhner H
    J Clin Oncol; 2006 Aug; 24(24):3887-94. PubMed ID: 16864856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
    Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
    J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma.
    Haven CJ; van Puijenbroek M; Karperien M; Fleuren GJ; Morreau H
    J Pathol; 2004 Jan; 202(1):86-94. PubMed ID: 14694525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors.
    Rosenberg CL; Kim HG; Shows TB; Kronenberg HM; Arnold A
    Oncogene; 1991 Mar; 6(3):449-53. PubMed ID: 2011400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.
    Bayani J; Brenton JD; Macgregor PF; Beheshti B; Albert M; Nallainathan D; Karaskova J; Rosen B; Murphy J; Laframboise S; Zanke B; Squire JA
    Cancer Res; 2002 Jun; 62(12):3466-76. PubMed ID: 12067990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells.
    Prasad M; Bernardini M; Tsalenko A; Marrano P; Paderova J; Lee CH; Ben-Dor A; Barrett MT; Squire JA
    Genes Chromosomes Cancer; 2008 May; 47(5):427-36. PubMed ID: 18273836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
    Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
    Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of myeloid sarcoma by array comparative genomic hybridization.
    Deeb G; Baer MR; Gaile DP; Sait SN; Barcos M; Wetzler M; Conroy JM; Nowak NJ; Cowell JK; Cheney RT
    Genes Chromosomes Cancer; 2005 Dec; 44(4):373-83. PubMed ID: 16080198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.
    Dwight T; Nelson AE; Theodosopoulos G; Richardson AL; Learoyd DL; Philips J; Delbridge L; Zedenius J; Teh BT; Larsson C; Marsh DJ; Robinson BG
    Am J Pathol; 2002 Oct; 161(4):1299-306. PubMed ID: 12368203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma.
    Freier K; Sticht C; Hofele C; Flechtenmacher C; Stange D; Puccio L; Toedt G; Radlwimmer B; Lichter P; Joos S
    Genes Chromosomes Cancer; 2006 Feb; 45(2):118-25. PubMed ID: 16235239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).
    Chapman EJ; Williams SV; Platt FM; Hurst CD; Chambers P; Roberts P; Knowles MA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):694-710. PubMed ID: 19405089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism.
    Bednarz N; Błaut K; Sworczak K; Oseka T; Bielawski KP
    Acta Biochim Pol; 2009; 56(1):83-8. PubMed ID: 19259547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.
    Libutti SK; Crabtree JS; Lorang D; Burns AL; Mazzanti C; Hewitt SM; O'Connor S; Ward JM; Emmert-Buck MR; Remaley A; Miller M; Turner E; Alexander HR; Arnold A; Marx SJ; Collins FS; Spiegel AM
    Cancer Res; 2003 Nov; 63(22):8022-8. PubMed ID: 14633735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.